VYCO~Vycor Medical's VBAS Granted Regulatory Clearance in China; Opening Order of $170,000 Shipped.

VYCO announced that its ViewSite Brain Access System ("VBAS") has received clearance from the State Food and Drug Administration ("SFDA") in the People's Republic of China ("PRC") to be imported and marketed in the PRC. This follows the issue of its patent in China for VBAS in 2011.
Kenneth Coviello, the Chief Executive of Vycor, commented: "We are delighted to have achieved this important milestone in Vycor's development. VBAS has received outstanding reviews from surgeons in the United States where it continues to gain traction with hospitals and neurosurgeons. We believe that the Chinese medical device market has tremendous potential for Vycor and are excited to begin working with healthcare professionals in China and look forward to the expansion of VBAS in the region."
Underlining the importance of this milestone, Vycor has received an opening order for the Chinese market with a value of $170,000, which it shipped prior to the end of December 2011.
For more information about how VBAS works, or to read testimonials, please visit www.vycormedical.com